Volume 72, Issue 7, Pages (October 2007)

Slides:



Advertisements
Similar presentations
Volume 70, Issue 7, Pages (October 2006)
Advertisements

Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein  Sarah Siggins, Igor Bykov, Martin Hermansson,
Volume 63, Issue 2, Pages (February 2003)
Volume 82, Issue 9, Pages (November 2012)
Sharon M. Moe, Gurinder K. Singh, Anna M. Bailey  Kidney International 
Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties by Vicent Ribas, José Luis Sánchez-Quesada,
Dyslipidemia in chronic kidney disease: Causes and consequences
Volume 66, Issue 4, Pages (October 2004)
Volume 69, Issue 1, Pages (January 2006)
Anan Abu Ubeid, Longmei Zhao, Ying Wang, Basil M. Hantash 
Anti-Psoriatic Therapy Recovers High-Density Lipoprotein Composition and Function  Michael Holzer, Peter Wolf, Martin Inzinger, Markus Trieb, Sanja Curcic,
Age-related variations in follicular apolipoproteins may influence human oocyte maturation and fertility potential  Tiffany Von Wald, M.D., Yevgeniya.
Volume 70, Issue 7, Pages (October 2006)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL  Gregory C. Shearer, William G. Couser,
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
Volume 61, Issue 4, Pages (April 2002)
IGF-1 vs insulin: Respective roles in modulating sodium transport via the PI-3 kinase/Sgk1 pathway in a cortical collecting duct cell line  E. Gonzalez-Rodriguez,
Volume 149, Issue 6, Pages (November 2015)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Direct Activation of Gastric H,K-ATPase by N-Terminal Protein Kinase C Phosphorylation. Comparison of the Acute Regulation Mechanisms of H,K-ATPase and.
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation  Graeme J. Gowans,
Keratinocyte-Specific Mesotrypsin Contributes to the Desquamation Process via Kallikrein Activation and LEKTI Degradation  Masashi Miyai, Yuuko Matsumoto,
TAT-mediated Delivery of LAD Restores Pyruvate Dehydrogenase Complex Activity in the Mitochondria of Patients with LAD Deficiency  Matan Rapoport, Ann.
Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome  Nosratola D.
Volume 73, Issue 5, Pages (March 2008)
Volume 69, Issue 8, Pages (April 2006)
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Indu Mani, Vincent A. Ziboh  Journal of Investigative Dermatology 
Mechanism of microthrombosis in HUS
Volume 59, Issue 6, Pages (June 2001)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells  I. Arany, J.K. Megyesi, B.D. Nelkin,
Volume 80, Issue 4, Pages (August 2011)
Volume 82, Issue 9, Pages (November 2012)
Jared C. Basham, Alexandra Chabrerie, Stephen A. Kempson 
Volume 56, Issue 4, Pages (October 1999)
Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL  Gregory C. Shearer, William G. Couser,
Volume 70, Issue 6, Pages (September 2006)
Protease activity of plasma hemopexin
Volume 60, Issue 3, Pages (September 2001)
Uremia impairs blood dendritic cell function in hemodialysis patients
New insights into lipid metabolism in the nephrotic syndrome
Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes 
Volume 62, Issue 5, Pages (November 2002)
Blood pressure targets in hemodialysis patients
Volume 62, Issue 6, Pages (December 2002)
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells  Gur P. Kaushal, Varsha Kaushal, Ph.D., Xiaoman.
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
Volume 69, Issue 1, Pages (January 2006)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 57, Issue 5, Pages (May 2000)
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
Eva Balint, Cory F. Marshall, Dr Stuart M. Sprague 
Volume 59, Issue 5, Pages (May 2001)
Schematic representation of dyslipidaemia of metabolic syndrome.
Volume 16, Issue 4, Pages (October 2012)
Volume 8, Issue 7, Pages (July 2001)
Volume 56, Issue 6, Pages (December 1999)
Volume 62, Issue 6, Pages (December 2002)
Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue- type plasminogen activator  Thomas Sitter, Karin Toet, Paul.
Volume 15, Issue 9, Pages (September 2008)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 59, Issue 1, Pages (January 2001)
Volume 77, Issue 5, Pages (March 2010)
Fibrinogen fragments and platelet dysfunction in uremia
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells  Yuzhi Hong, Wuding Zhou, Ke Li,
Presentation transcript:

Volume 72, Issue 7, Pages 871-878 (October 2007) Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase  G. Dautin, Z. Soltani, D. Ducloux, T. Gautier, J.P. Pais de Barros, P. Gambert, L. Lagrost, D. Masson  Kidney International  Volume 72, Issue 7, Pages 871-878 (October 2007) DOI: 10.1038/sj.ki.5002449 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 ApoC-I content in total blood plasma before and after HD. Blood samples were collected immediately before and after HD. Apolipoprotein C-I concentrations were determined by a specific ELISA as described in ‘Materials and Methods’. Results are expressed as apoC-I to total protein ratio. Values are mean±s.d. (bold type). *P<0.01 Wilcoxon test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 ApoC-I content of HDL before and after HD. Blood samples were collected immediately before and after HD, and HDL were isolated by sequential ultracentrifugation as described in ‘Materials and Methods’. Apolipoprotein C-I concentrations were determined by a specific ELISA as described in ‘Materials and Methods’. Results are expressed as apoC-I to apoA-I ratios. Values are mean±S.D. (bold type). NS: no significant differences by Wilcoxon test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 ApoC-I content of VLDL before and after HD. Blood samples were collected immediately before and after HD, and VLDL were isolated by sequential ultracentrifugation as described in ‘Materials and Methods’. Apolipoprotein C-I concentrations were determined by a specific ELISA as described in ‘Materials and Methods’. Results are expressed as apoC-I to apoB ratio. Values are mean±s.d. (bold type). *P<0.01 Wilcoxon test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Apolipoprotein composition of pre- and post-dialysis VLDL. VLDL were isolated by sequential ultracentrifugation from pre- or post-dialysis plasmas, and their apolipoprotein contents were analyzed on an sodium dodecyl sulfate-polyacrylamide gradient gel (a) by coomassie staining or (b) by Western blot analysis using anti apolipoprotein C-I antibodies. 1: Molecular weight markers, 2: purified apoC-I, 3: pre-dialysis VLDL, 4: post-dialysis VLDL. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Time course analysis of the apo C-I content of VLDL. Blood samples were collected before (t=0) and after the dialysis session (2 and 24 h). VLDL were isolated by sequential ultracentrifugation, and apolipoprotein C-I concentrations were determined by a specific ELISA as described in ‘Materials and Methods’. ApoC-I level in VLDL was compared to 100%, t=0 controls. Values are mean±s.d. *P<0.01 vs T0; Wilcoxon test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 6 Comparison of the ability of pre- or post-dialysis VLDL to interact with CETP. VLDL were isolated by sequential ultracentrifugation from pre- or post-dialysis plasmas. Cholesteryl ester transfer activity was determined as the rate of transfer of fluorescent NBD-cholesteryl esters from labeled liposome donors to HDL acceptors in the presence of a purified CETP fraction (final protein concentration, 8 μg) along a 3-h incubation period at 37°C (see ‘Materials and Methods’). Blank values were obtained with homologous, incubated mixtures to which no purified CETP was added. Values are mean±s.d. of three determinations. No significant differences were observed by Wilcoxon test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 7 Effect of VLDL concentrations on the CETP inhibitory potential of apoC-I. Cholesteryl ester transfer activity was determined as the rate of transfer of fluorescent NBD-cholesteryl esters from labeled liposome donors (phospholipids, 5 μmol/l) to VLDL acceptors (range, 10–500 μmol/l) in the presence of purified CETP (8 μg) in a final volume of 200 μl. Incubations were conducted for 3 h at 37°C in the absence or in the presence of purified apoC-I (concentration, 0.5 μmol/l). ApoC-I to TGs ratio was calculated by taking into account both the quantity of purified apo C-1 added to the incubation media (0.5 μM) and the VLDL-associated apoC-I (0.012 mol apo C1/mole TG). Percentage of CETP inhibition (vertical bars) was calculated by comparing the initial transfer rate in the presence of apoC-I to the initial transfer rate with no apoC-I added. Transfer rates were determined from the linear, initial portion of the time course curves. Values are mean±s.d. of three determinations. *Significantly different from mixtures containing 0.5 μmol/l of apoC-I, P<0.05; Mann–Whitney test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 8 Comparison of the ability of pre- or post-dialysis VLDL to act as substrates for LPL. VLDL were isolated by sequential ultracentrifugation from pre- or post-dialysis plasmas. VLDL (60 nmol TGs/assay) were incubated in the presence of purified LPL (purified from bovine milk, Sigma) in 10 μl Tris-buffer (0.1 M Tris, pH 8.5) at 37°C for 6 min. The reaction was stopped by the addition of Triton X-100, vortexing and cooling on ice. A blank sample was obtained in parallel by adding Triton before the addition of LPL and maintenance on ice. Aliquots of the samples were used to determine FFA concentrations in triplicate using an enzymatic assay. LPL activity was expressed as the amount of FFA released from VLDL during the incubation period. Values are mean±s.d. P<0.05 Wilcoxon test. Kidney International 2007 72, 871-878DOI: (10.1038/sj.ki.5002449) Copyright © 2007 International Society of Nephrology Terms and Conditions